Latest News

Home Bancshares stock performance snapshot Home Bancshares (HOMB) has been trading under pressure recently, with the share price around $26.31 and negative returns over the past week, month, past 3 months, year to date, and past year. At the same time, the bank reports annual revenue of about $1.07b and net income of roughly $475.44m, alongside positive multi year total returns. This presents investors with a mixed set of signals to weigh. See our latest analysis for Home Bancshares (Conway...

Earlier this month, Zealand Pharma reported positive topline Phase 2 ZUPREME-1 results showing petrelintide achieved statistically significant, clinically meaningful weight loss with tolerability similar to placebo in people living with overweight and obesity. The data suggest petrelintide’s once-weekly amylin-based profile could offer a differentiated, potentially more tolerable alternative to existing peptide weight-loss therapies, reinforcing Zealand’s obesity franchise with Roche. We’ll...

In early March 2026, Match Group, Inc. announced that the Chief Operating Officer role will be eliminated on June 2, 2026, leading long-time executive Hesam Hosseini to depart after more than 15 years with the company. This leadership change comes as analysts highlight faster product experimentation and early engagement improvements at Tinder, raising questions about how Match Group’s operating structure will support its product-led refresh. We’ll now examine how Tinder’s faster product...

TELUS Corporation recently confirmed a significant cybersecurity breach at its digital services arm, where threat actors allegedly accessed nearly 1 petabyte of customer and call data, prompting an ongoing investigation and remediation efforts. This incident highlights growing operational and reputational risks for TELUS as it expands into higher-value digital and technology services alongside its core telecom operations. We’ll now examine how this large-scale cybersecurity breach may...

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...

In recent months, Haemonetics has reported a recovery in its Hospital division, underpinned by growing adoption of its FDA-approved NexSys PCS system with Persona Technology and supported by acquisitions broadening its presence in esophageal protection and interventional cardiology. An interesting angle is how this combination of higher-margin NexSys PCS usage and newly acquired hospital technologies is helping Haemonetics improve operational efficiency while deepening its role inside...

Why Lepu Biopharma’s Latest Guidance Matters Lepu Biopharma (SEHK:2157) has drawn fresh attention after issuing earnings guidance that points to at least RMB 200 million in net profit for 2025, compared with a RMB 411 million loss in 2024. The company links this projected swing to revenue from PUYOUHENG and newly approved MEIYOUHENG, expanded licensing income, and a one off reclassification gain on an investment, while an upcoming March 25 board meeting will review the full 2025 results and...

Why ServiceTitan stock is back in focus ServiceTitan (TTAN) is drawing fresh attention after a busy set of March updates, including fourth quarter and full year results, new revenue guidance, and a leadership hire focused squarely on AI. See our latest analysis for ServiceTitan. ServiceTitan shares have been volatile around the recent earnings release and AI focused leadership appointment, with a 1 day share price return of 6.41% decline and a 7 day share price return of 14.65% decline. The...

In recent weeks, Enbridge approved two large-scale U.S. renewable energy projects worth about US$1.60 billion and expanded its secured growth backlog to CA$39.00 billion, while highlighting contract-backed infrastructure, diversified operations and a multi-decade record of dividend increases in its 2026 Management Information Circular. The company is also targeting rising data-center energy demand through more than 50 prospective projects across North America, including a Texas wind...

In recent days, Alpha Metallurgical Resources director Kenneth S. Courtis has purchased multiple blocks of company stock totaling tens of thousands of shares, lifting his direct ownership to more than 866,000 shares and adding to a year-long pattern of insider buying without any reported sales. This sustained accumulation by a board member, coming shortly after a weaker fourth quarter marked by pressure on coal margins, highlights a clear alignment between leadership and shareholders at a...

If you are wondering whether STMicroelectronics is attractively priced today, this article will walk you through how its current share price stacks up against several valuation checks. The stock closed at €28.62, with returns of 5.4% over the last 7 days, 0.6% over 30 days, 22.1% year to date, 28.3% over 1 year, a 35.1% decline over 3 years and a 3.5% decline over 5 years. These figures can shape how investors see its growth potential and risk profile. Recent attention around...

On March 5, 2026, Popular, Inc. declared a monthly cash dividend of US$0.132813 per share on its 6.375% Non-Cumulative Monthly Income Preferred Stock, 2003 Series A, payable on March 31, 2026 to shareholders of record as of March 15, 2026, and earlier in the month its CEO presented at the RBC Capital Markets Global Financial Institutions Conference in New York. The combination of a continued preferred dividend payout and management’s public commentary on capital return, digital investments,...

Why RPC (RES) is on investors’ radar RPC (RES) has drawn attention after recent trading left the stock at $6.52, with returns over the past month and past 3 months outpacing its 1 day performance. Investors are weighing that shift against fundamentals. See our latest analysis for RPC. Zooming out, RPC’s 1 year total shareholder return of 26.01% alongside a 17.90% year to date share price return suggests recent momentum is building despite a softer 1 day move. If RPC’s recent run has you...

North American Construction Group Ltd. recently reported full-year 2025 results showing sales rising to C$1,284.29 million while net income fell to C$33.83 million, alongside a quarterly dividend declaration of C$0.12 per share, updated 2026 revenue guidance of C$1.5–C$1.7 billion, and completion of a 407,616‑share buyback. These results highlight a tension between higher revenue and weaker earnings, as project cost adjustments, weather-related disruptions, major Australian contract wins,...

Gaztransport & Technigaz (ENXTPA:GTT) is back on investors’ radar after securing a fresh order to design the liquefied natural gas tank system for a new carrier from HD Korea Shipbuilding & Offshore Engineering. See our latest analysis for Gaztransport & Technigaz. The new LNG carrier contract lands after a strong run, with a 30 day share price return of 9.43%, a 90 day share price return of 22.76%, and a 1 year total shareholder return of 45.37%. This suggests momentum has been building over...

In its latest quarterly update, ITT reported past revenues of US$1.05 billion, up 13.5% year on year and above analyst expectations, while also closing its acquisition of SPX FLOW and renaming its Industrial Process segment to Flow Technologies under new leadership. Together, the earnings surprise and SPX FLOW integration mark a significant broadening of ITT’s global flow technologies platform and shift in its business mix beyond purely organic growth. We’ll now examine how ITT’s revenue...

If you have been wondering whether NVIDIA's current price really stacks up against its fundamentals, you are not alone. This article is designed to help you frame that question clearly. NVIDIA's share price recently closed at US$180.25, with returns of 1.4% over 7 days, a 1.4% decline over 30 days, a 4.6% decline year to date, and a 48.2% gain over the last year, while the 3 year return has been very large. Recent news coverage has focused on NVIDIA's central role in graphics processing...

Illinois Tool Works overview after recent share performance Illinois Tool Works (ITW) has drawn fresh investor attention after recent share performance, with the stock up 0.5% over the past day, softer over the past week and month, but slightly positive over the past 3 months. See our latest analysis for Illinois Tool Works. At a share price of US$266.99, Illinois Tool Works has seen short term momentum fade, with a 30 day share price return decline of 10.88%. However, its 1 year total...

On 9 March 2026, Kelun-Biotech and Harbour BioMed announced that China’s NMPA approved the IND application for SKB575/HBM7575, a long-acting bispecific antibody for atopic dermatitis with a dual TSLP-based mechanism and extended half-life enabling subcutaneous dosing. This IND approval highlights Kelun-Biotech’s growing capabilities in innovative biologics and positions SKB575/HBM7575 as a potentially differentiated long-interval therapy candidate in atopic dermatitis. We will now examine...

Recent bullish commentary from Jim Cramer on Energy Transfer (ET), combined with analyst upgrades and increased holdings by Recurrent Investment Advisors, has put fresh attention on the pipeline operator’s fundamentals and valuation. See our latest analysis for Energy Transfer. At a share price of US$18.75, Energy Transfer has seen a 13.6% 90 day share price return and a 13% year to date share price return. Its 5 year total shareholder return of 248.16% contrasts with a far more modest 8.06%...

Bilibili Inc. has reported full-year 2025 results, with sales rising to CNY 6,394.64 million and total revenue reaching CNY 30,347.77 million, while net income improved to CNY 1,193.53 million compared with a net loss in the prior year. The shift from a loss per share to basic earnings per share of CNY 2.85 from continuing operations marks a clear return to profitability that reshapes how investors may view the platform’s underlying business quality. We will now examine how Bilibili’s return...

If you are wondering whether Incyte at around US$92.54 is offering good value or asking too much, you are not alone. This article is written for that exact question. The share price has seen mixed moves, with a 3.5% decline over the last 7 days and an 8.5% decline over the past month, alongside longer term returns of 36.4% over 1 year, 25.7% over 3 years and 16.6% over 5 years. Recent attention on Incyte has been shaped by ongoing product and pipeline updates, regulatory milestones and...

GEO Group (GEO) is in the spotlight after long serving Chief Financial Officer Mark J. Suchinski decided to leave at the end of March, with veteran finance executive Shayn March stepping into the role. See our latest analysis for GEO Group. The CFO transition comes after a mixed run for investors, with GEO’s share price at US$14.55 posting a 3.2% one day gain and a 2.4% 30 day share price return. Its 1 year total shareholder return shows a 45.3% decline, while its 3 year and 5 year total...

In March 2026, Codexis reported fourth-quarter 2025 results showing revenue of US$38.92 million and net income of US$9.6 million, reversing a prior-year loss and beating analyst expectations, alongside full-year 2025 revenue of US$70.39 million and guidance for 2026 revenue of US$72 million to US$76 million. The quarter was heavily influenced by a large technology transfer agreement with Merck and growing ECO Synthesis platform activity, which also underpins management’s view that existing...